Skip to main navigation Skip to search Skip to main content

Pomalidomide + Low-Dose Dexamethasone + Daratumumab in Relapsed and/or Refractory Multiple Myeloma after Lenalidomide-Based Treatment Failure

  • David S Siegel
  • , Gary J. Schiller
  • , Christy J. Samaras
  • , Michael Sebag
  • , Jesus G. Berdeja
  • , Siddhartha Ganguly
  • , Jeffrey V Matous
  • , Kevin Song
  • , Christopher S. Seet
  • , Giampaolo Talamo
  • , Mirelis Acosta-Rivera
  • , Michael Bar
  • , Donald P. Quick
  • , Bertrand Anz
  • , Gustavo Fonseca
  • , Donna Reece
  • , Amit Agarwal
  • , Weiyuan Chung
  • , Faiza Zafar
  • , Nizar Bahlis
  • Hackensack University Medical Center
  • University of California, Los Angeles
  • Cleveland Clinic
  • McGill University Health Centre
  • Sarah Cannon Research Institute
  • University of Kansas
  • Colorado Blood Cancer Institute, Denver, CO
  • Vancouver General Hospital
  • UCLA Medical Center
  • Penn State Cancer Institute
  • Fundacion de Investigacion, San Juan, Puerto Rico
  • Stamford Hospital
  • Joe Arrington Cancer Research Treatment Center, Lubbock, TX
  • Tennessee Oncology, Chattanooga, TN
  • Florida Cancer Specialists, St Petersburg, FL
  • Princess Margaret Cancer Centre
  • Celgene
  • University of Calgary

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume132
DOIs
StatePublished - Nov 29 2018
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Internal Medicine

Cite this